4.7 (318) · € 27.99 · Auf Lager
Metabolism of Delavirdine, a Human Immunodeficiency Virus Type-1 Reverse Transcriptase Inhibitor, by Microsomal Cytochrome P450 in Humans, Rats, and Other Species: Probable Involvement of CYP2D6 and CYP3A
Cells, Free Full-Text
PDF] Metabolism of the human immunodeficiency virus type 1 reverse transcriptase inhibitor delavirdine in rats.
IJMS, Free Full-Text
Delavirdine
Approved HIV reverse transcriptase inhibitors in the past decade - ScienceDirect
Metabolism of Delavirdine, a Human Immunodeficiency Virus Type-1 Reverse Transcriptase Inhibitor, by Microsomal Cytochrome P450 in Humans, Rats, and Other Species: Probable Involvement of CYP2D6 and CYP3A
Metabolism of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitor Delavirdine in Rats
Frontiers Human immunodeficiency virus and antiretroviral therapy-mediated immune cell metabolic dysregulation in children born to HIV-infected women: potential clinical implications
AvD delivery system for enhanced bioactivity & PK properties
HIV and antiretroviral therapy-related fat alterations